Skip to main content
Article thumbnail
Location of Repository

A compact VEGF signature associated with distant metastases and poor outcomes

By Zhiyuan Hu, Cheng Fan, Chad Livasy, Xiaping He, Daniel S Oh, Matthew G Ewend, Lisa A Carey, Subbaya Subramanian, Robert West, Francis Ikpatt, Olufunmilayo I Olopade, Matt van de Rijn and Charles M Perou
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2671523
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2002). A gene-expression signature as a predictor of survival in breast cancer.
    2. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell
    3. (2007). AL: Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers. Cancer Res
    4. (2002). Botstein D: Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell
    5. (2003). Botstein D: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA
    6. (2005). Chodosh LA: The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell
    7. (2001). Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA
    8. (1998). Cluster analysis and display of genome-wide expression patterns.
    9. (2005). der: Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.
    10. (2002). Diagnosis of multiple cancer types by shrunken centroids of gene expression.
    11. (2003). DN: Gene expressionbased classification of malignant gliomas correlates better with survival than histological classification. Cancer Res
    12. (2002). EM: rVista for comparative sequence-based discovery of functional transcription factor binding sites. Genome Res
    13. (2008). Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res
    14. (2005). Foekens JA: Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet
    15. (2006). Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers. PLoS Med
    16. (2004). Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol
    17. (2005). Genes that mediate breast cancer metastasis to lung. Nature
    18. (2004). Java Treeview – extensible visualization of microarray data. Bioinformatics
    19. (2004). JS: Adjustment of systematic microarray data biases. Bioinformatics
    20. (2005). Kakudo K: Urokinasetype plasminogen activator system and breast cancer (Review). Oncol Rep
    21. (2008). KM: Adrenomedullin signaling is necessary for murine lymphatic vascular development.
    22. (2001). MA: HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. Cancer Res
    23. (2005). Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.
    24. (2005). MJ: Myoepithelial cells: good fences make good neighbors. Breast Cancer Res
    25. (2004). Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell
    26. (2000). Molecular portraits of human breast tumours. Nature
    27. (2006). N-myc down-regulated gene 1 modulates the response of term human trophoblasts to hypoxic injury.
    28. (1956). On respiratory impairment in cancer cells. Science
    29. (2006). Pawitan Y: Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res
    30. (2001). Perou CM: A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines. Dis Markers
    31. (2006). Perou CM: Common markers of proliferation. Nat Rev Cancer
    32. (2006). Perou CM: Concordance among gene-expressionbased predictors for breast cancer.
    33. (2006). Perou CM: Estrogen-Regulated Genes Predict Survival in Hormone Receptor-Positive Breast Cancers. J Clin Oncol
    34. (2006). Perou CM: Gene expression patterns associated with p53 status in breast cancer.
    35. (2005). Perou CM: High reproducibility using sodium hydroxide-stripped long oligonucleotide DNA microarrays. Biotechniques
    36. (2004). Perou CM: Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell
    37. (2005). Perou CM: Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol
    38. (2006). Perou CM: The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics
    39. (2000). PO: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet
    40. (1999). PO: The transcriptional program in the response of human fibroblasts to serum [see comments]. Science
    41. (2001). PS: Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res
    42. (2003). RA: Identifying biological themes within lists of genes with EASE. Genome Biol
    43. (2006). RC: Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. Jama
    44. (2005). REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase. Oncogene
    45. (2004). Rimm DL: X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cutpoint optimization. Clin Cancer Res
    46. (1999). RJ: GATA-3 is expressed in association with estrogen receptor in breast cancer.
    47. (2002). SH: Gene expression profiling predicts clinical outcome of breast cancer.
    48. (2001). Significance analysis of microarrays applied to the ionizing radiation response.
    49. (2007). Sledge GW Jr: Drug insight: VEGF as a therapeutic target for breast cancer. Nat Clin Pract Oncol
    50. (2005). T: [Functional analyses of NDRG1, a stress-responsive gene]. Seikagaku
    51. (2001). The metabolism of tumours': 70 years later. Novartis Found Symp
    52. (2001). The prognostic role of angiogenesis in breast cancer. Anticancer Res
    53. (2005). The proinflammatory cytokine interleukin 1beta and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation. Cancer Res
    54. (2003). TR: A molecular signature of metastasis in primary solid tumors. Nat Genet
    55. (2004). Universal Reference RNA as a standard for microarray experiments. BMC Genomics
    56. (2003). van't Veer LJ: Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA
    57. (2005). Van't Veer LJ: Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res
    58. (2005). Vijver MJ van de: Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA
    59. (2002). Weinberg RA: A progression puzzle.
    60. (2004). Weinberg RA: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell
    61. (2002). Werb Z: Stromal effects on mammary gland development and breast cancer. Science
    62. (2004). Wolmark N: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.